Search Results - "Luan, F. L."

Impact of Cytomegalovirus Disease in D+/R– Kidney Transplant Patients Receiving 6 Months Low‐Dose Valganciclovir Prophylaxis by Luan, F. L., Kommareddi, M., Ojo, A. O.

“…Late‐onset cytomegalovirus (CMV) disease remains common in CMV serology naïve kidney transplant patients of CMV serology positive organs (D+/R–) despite the…”
Get full text

Graft and Patient Survival in Kidney Transplant Recipients Selected for de novo Steroid‐Free Maintenance Immunosuppression by Luan, F. L., Steffick, D. E., Gadegbeku, C., Norman, S. P., Wolfe, R., Ojo, A. O.

“…Steroid‐free regimen is increasingly employed in kidney transplant recipients across transplant centers. However, concern remains because of the unknown impact…”
Get full text

Influence of Recipient Race on the Outcome of Simultaneous Pancreas and Kidney Transplantation by Luan, F. L., Kommareddi, M., Cibrik, D. M., Samaniego, M., Ojo, A. O.

“…Racial differences on the outcome of simultaneous pancreas and kidney (SPK) transplantation have not been well studied. We compared mortality and graft…”
Get full text

Comparative Risk of Impaired Glucose Metabolism Associated with Cyclosporine Versus Tacrolimus in the Late Posttransplant Period by Luan, F. L., Zhang, H., Schaubel, D. E., Miles, C. D., Cibrik, D., Norman, S., Ojo, A. O.

“…New onset diabetes after transplantation (NODAT) and impaired fasting glucose (IFG) are common in kidney transplant recipients (KTRs). Calcinuerin inhibitor…”
Get full text

Efficacy and Safety of Everolimus Plus Low‐Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard‐Dose Tacrolimus in De Novo Renal Transplant Recipients: 12‐Month Data by Qazi, Y., Shaffer, D., Kaplan, B., Kim, D. Y., Luan, F. L., Peddi, V. R., Shihab, F., Tomlanovich, S., Yilmaz, S., McCague, K., Patel, D., Mulgaonkar, S.

“…In this 12‐month, multicenter, randomized, open‐label, noninferiority study, de novo renal transplant recipients (RTxRs) were randomized (1:1) to receive…”
Get full text

Early hospital readmissions post-kidney transplantation are associated with inferior clinical outcomes by Luan, F. L., Barrantes, F., Roth, R. S., Samaniego, M.

“…Unplanned hospital readmissions are common early post‐kidney transplantation. We investigated the relationship between early hospital readmissions and clinical…”
Get full text

Six-Month Low-Dose Valganciclovir Prophylaxis in Cytomegalovirus D+/R− Kidney Transplant Patients Receiving Thymoglobulin Induction by Luan, F.L

“…Abstract Background The use of T-cell-depleting antibody, such as thymoglobulin, is a risk factor for cytomegalovirus (CMV) infection. We studied the…”
Get full text

Efficacy of Valganciclovir in the Treatment of Cytomegalovirus Disease in Kidney and Pancreas Transplant Recipients by Luan, F.L., Chopra, P., Park, J., Norman, S., Cibrik, D., Ojo, A.

“…Cytomegalovirus (CMV) disease is relatively common following solid organ transplant, particularly if a serologically negative recipient receives an organ from…”
Get full text

Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients by Luan, F.L., Samaniego, M., Kommareddi, M., Park, J.M., Ojo, A.O.

“…F.L. Luan, M. Samaniego, M. Kommareddi, J.M. Park, A.O. Ojo. Choice of induction regimens on the risk of cytomegalovirus infection in donor‐positive and…”
Get full text

Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy by LUAN, Fu L, HOJO, Minoru, MALUCCIO, Mary, YAMAJI, Kouzaburo, SUTHANTHIRAN, Manikkam

“…Malignancy is a dreaded complication of organ transplantation. Immunosuppressive drug therapy-induced impairment of the organ graft recipient's immune…”
Get full text

Geographical clustering of scleroderma in a rural area in the province of Rome by Valesini, G, Litta, A, Bonavita, M S, Luan, F L, Purpura, M, Mariani, M, Balsano, F

“…A geographical cluster of scleroderma and scleroderma-related features was identified in a rural area in the province of Rome. Two patients with scleroderma,…”
Get more information

Chronic fatigue : a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents by PERIORI, R, CONTI, F, LUAN, F. L, ARPINO, C, VALESINI, G

“…We describe four Italian adolescents in whom a persistent, debilitating fatigue appeared after therapeutic ingestion of products containing L-tryptophan and…”
Get full text

Treating patients with severe sepsis by Luan, F L

Get full text

The plasma cofactor and anticardiolipin antibodies by Allegri, F, Balestrieri, G, Cattaneo, R, Martinelli, M, Tincani, A, Barcellini, W, Del Papa, N, Meroni, P L, Falco, M, Luan, F L

Get more information

Novel views on new-onset diabetes after transplantation: development, prevention and treatment by Hecking, Manfred, Werzowa, Johannes, Haidinger, Michael, Hörl, Walter H, Pascual, Julio, Budde, Klemens, Luan, Fu L, Ojo, Akinlolu, de Vries, Aiko P J, Porrini, Esteban, Pacini, Giovanni, Port, Friedrich K, Sharif, Adnan, Säemann, Marcus D

“…New-onset diabetes after transplantation (NODAT) is associated with increased risk of allograft failure, cardiovascular disease and mortality, and therefore,…”
Get full text

Comparison of the long-term outcomes of kidney transplantation: USA versus Spain by Ojo, Akinlolu O, Morales, José María, González-Molina, Miguel, Steffick, Diane E, Luan, Fu L, Merion, Robert M, Ojo, Tammy, Moreso, Francesc, Arias, Manuel, Campistol, Josep María, Hernandez, Domingo, Serón, Daniel

“…The long-term outcomes of kidney transplantation are suboptimal because many patients lose their allografts or experience premature death. Cross-country…”
Get full text

Human anticardiolipin monoclonal autoantibodies cause placental necrosis and fetal loss in BALB/c mice by Ikematsu, W, Luan, F L, La Rosa, L, Beltrami, B, Nicoletti, F, Buyon, J P, Meroni, P L, Balestrieri, G, Casali, P

“…To analyze the structure, specificity, and in vivo pathogenetic potential of 2 human anticardiolipin (aCL) monoclonal antibodies (MAb). Human aCL IgG MAb were…”
Get more information

EVOLUTION OF GLUCOSE METABOLISM EARLY AFTER KIDNEY TRANSPLANTATION USING THE LATEST AMERICAN DIABETES ASSOCIATION GUIDELINE: 1162 by Luan, F. L., Ojo, A. O.

Get full text

New-Onset Diabetes Mellitus in Kidney Transplant Recipients Discharged on Steroid-Free Immimosuppression by Luan, F L, Steffick, DE, Ojo, A O

“…Background. New-onset diabetes after transplant (NODAT) is a serious complication after kidney transplantation. We studied the relationship between…”
Get full text

Early Pancreas Graft Failure Is Associated With Inferior Late Clinical Outcomes After Simultaneous Kidney-Pancreas Transplantation by NORMAN, Silas P, KOMMAREDDI, Mallika, OJO, Akinlolu O, LUAN, Fu L

“…Early pancreas graft failure after simultaneous pancreas and kidney (SPK) transplantation is common. We studied the impact of early pancreas graft failure on…”
Get full text